<?xml version="1.0" encoding="UTF-8" ?>
			<?xml-stylesheet href="/rss/rss2html.xsl" type="text/xsl" media="screen"?>
			<rss version="2.0" xmlns:alacra="http://www.alacra.com" xmlns:bir="http://www.alacra.com/bir" xmlns:ccbn="http://www.alacra.com/ccbn" xmlns:spcred="http://www.alacra.com/spcred" xmlns:newstex="http://www.alacra.com/newstex" ><channel><title>Stryker Corporation RSS Research Feed - Subscribe Today - AlacraStore.com</title>
<description>Stryker Corporation</description>
<link>http://www.alacrastore.com/company-snapshot/Stryker_Corporation-1016012</link>
<lastBuildDate>Saturday, July 26, 2008 1:46:09 PM</lastBuildDate>
<alacra:xlsid>1016012</alacra:xlsid>
<alacra:company>Stryker Corporation</alacra:company>
<language>en</language>
<generator>AlacraStore RSS Builder 1.0</generator>
<ttl>30</ttl>
<item><link>http://www.alacrastore.com/storecontent/newstex/PRN-0005-26757450</link><guid isPermaLink="false">newstex/PRN-0005-26757450</guid><newstex:index_mode xmlns:newstex="http://www.alacra.com/newstex">xml</newstex:index_mode><description> DALLAS, Jul. ##, #### (PRNewswire-FirstCall delivered by Newstex) -- Texas Instruments (TI) (NYSE: TXN) today announced that Stephen MacMillan, president and chief executive officer of Stryker Corporation, has been elected to TI's board...</description><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">09000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">09015000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">11000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">11006000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016008</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04002000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04002006</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04003000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04003004</newstex:cat><pubDate>7/18/2008 8:16:24 AM</pubDate><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18000000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18007000</newstex:event><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19000000</newstex:geo><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19001000</newstex:geo><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19001043</newstex:geo><newstex:Publication xmlns:newstex="http://www.alacra.com/newstex">PR Newswire US</newstex:Publication><title>Stryker CEO Stephen MacMillan to join TI board of directors</title><newstex:docid xmlns:newstex="http://www.alacra.com/newstex">PRN-0005-26757450</newstex:docid><newstex:index_entry_company xmlns:newstex="http://www.alacra.com/newstex">JOHNSON &amp; JOHNSON</newstex:index_entry_company><newstex:index_entry_company xmlns:newstex="http://www.alacra.com/newstex">MERCK &amp; CO INC</newstex:index_entry_company><newstex:index_entry_company xmlns:newstex="http://www.alacra.com/newstex">STRYKER CORP</newstex:index_entry_company><newstex:index_entry_company xmlns:newstex="http://www.alacra.com/newstex">TEXAS INSTRUMENTS INC</newstex:index_entry_company><newstex:index_entry_person xmlns:newstex="http://www.alacra.com/newstex">RUTH J SIMMONS</newstex:index_entry_person><newstex:index_entry_person xmlns:newstex="http://www.alacra.com/newstex">STEPHEN P MACMILLAN</newstex:index_entry_person><newstex:index_entry_ticker xmlns:newstex="http://www.alacra.com/newstex">JNJ</newstex:index_entry_ticker><newstex:index_entry_ticker xmlns:newstex="http://www.alacra.com/newstex">MRK</newstex:index_entry_ticker><newstex:index_entry_ticker xmlns:newstex="http://www.alacra.com/newstex">SYK</newstex:index_entry_ticker><newstex:index_entry_ticker xmlns:newstex="http://www.alacra.com/newstex">TXN</newstex:index_entry_ticker><category>News</category><alacra:ip>Newstex</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/B1791623</link><guid isPermaLink="false">ccbn/B1791623</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><description>...SYK reported unique set of businesses delivered strong results again in #Q##, posting ##th straight qtr. of double-digit sales growth. ...

</description><pubDate>7/17/2008 8:06:14 PM</pubDate><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">Stryker</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">106.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Edited</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">Q2 2008 Stryker Earnings Conference Call Summary</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">SYK</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">4:30pm ET</ccbn:time><title>Q2 2008 Stryker Earnings Conference Call Summary</title><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Brief</ccbn:type><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">B1791623</ccbn:docid><category>Credit &amp; Investment Research</category><alacra:ip>Thomson Street Events</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/T1791623</link><guid isPermaLink="false">ccbn/T1791623</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><description>...Good day, ladies and gentlemen. Welcome to the Stryker conference call. My name is Katie, and I will be your coordinator for today. At this time, all participants will be in listen-only mode. We will be conducting a question-and-answer session towards ...

</description><pubDate>7/17/2008 8:06:14 PM</pubDate><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">Stryker</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">106.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Final</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">Q2 2008 Stryker Earnings Conference Call Transcript</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">SYK</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">4:30pm ET</ccbn:time><title>Q2 2008 Stryker Earnings Conference Call Transcript</title><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Transcript</ccbn:type><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">T1791623</ccbn:docid><category>Credit &amp; Investment Research</category><alacra:ip>Thomson Street Events</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/newstex/PRN-0005-26742403</link><guid isPermaLink="false">newstex/PRN-0005-26742403</guid><newstex:index_mode xmlns:newstex="http://www.alacra.com/newstex">xml</newstex:index_mode><description> KALAMAZOO, Mich., Jul. ##, #### (PRNewswire-FirstCall delivered by Newstex) -- Stryker Corporation (NYSE: SYK) reported operating results for the quarter ended June ##, #### as follows:                          Second Quarter Highlights...</description><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016048</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016018</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016001</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016047</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016003</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04009000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04009002</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04006000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04006002</newstex:cat><pubDate>7/17/2008 5:20:14 PM</pubDate><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18000000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18008000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18004000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18010000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18012000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18020000</newstex:event><newstex:Publication xmlns:newstex="http://www.alacra.com/newstex">PR Newswire US</newstex:Publication><title>Stryker Operating Results for Quarter Ended June 30, 2008</title><newstex:docid xmlns:newstex="http://www.alacra.com/newstex">PRN-0005-26742403</newstex:docid><newstex:index_entry_company xmlns:newstex="http://www.alacra.com/newstex">STRYKER CORP</newstex:index_entry_company><newstex:index_entry_person xmlns:newstex="http://www.alacra.com/newstex">STEPHEN P MACMILLAN</newstex:index_entry_person><newstex:index_entry_ticker xmlns:newstex="http://www.alacra.com/newstex">SYK</newstex:index_entry_ticker><category>News</category><alacra:ip>Newstex</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/T1791618</link><guid isPermaLink="false">ccbn/T1791618</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><description>...Good day, ladies and gentlemen, and welcome to the Q# #### Stryker earnings conference call. I will be your coordinator for today. We will conduct a question and answer session towards the end of this conference. (OPERATOR INSTRUCTIONS) As a reminder, this conference is being recorded for replay purposes. Before we begin, the Company would like everyone to know that certain statements made in today's conference call may constitute forward-looking statements. They will be based upon management's current expectations, will be subject to various risks and uncertainties that could cause the Company's actual results to differ materially from those expressed or implied in such statements. In addition to factors that may be discussed in this call, such factors include but are not limited to; pricing pressures generally, including cost containment measures that could adversely affect the price of or demand for the Company's products, regulatory actions, unanticipated issues arising in connection...

</description><pubDate>7/16/2008 4:55:28 PM</pubDate><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">Stryker</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">54.0000</ccbn:price><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">Q1 2008 Stryker Earnings Conference Call</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">SYK</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">4:30PM ET</ccbn:time><title>Q1 2008 Stryker Earnings Conference Call</title><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Transcript</ccbn:type><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">T1791618</ccbn:docid><category>Credit &amp; Investment Research</category><alacra:ip>Thomson Street Events</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/B1791618</link><guid isPermaLink="false">ccbn/B1791618</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><description>...SYK reported #Q## sales of $#.##b and diluted net EPS of $#.##. #Q## net earnings from continuing operations grew ##%. Co. feels good about its ability to deliver on its ##% EPS goal for ####. ...

</description><pubDate>7/16/2008 4:55:24 PM</pubDate><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">Stryker</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">54.0000</ccbn:price><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">Q1 2008 Stryker Earnings Conference Call</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">SYK</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">4:30PM ET</ccbn:time><title>Q1 2008 Stryker Earnings Conference Call</title><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Brief</ccbn:type><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">B1791618</ccbn:docid><category>Credit &amp; Investment Research</category><alacra:ip>Thomson Street Events</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/spcred/657331</link><guid isPermaLink="false">spcred/657331</guid><spcred:index_mode xmlns:spcred="http://www.alacra.com/spcred">norm</spcred:index_mode><description>The latest Full Report from S&amp;P</description><spcred:dataset xmlns:spcred="http://www.alacra.com/spcred">global</spcred:dataset><pubDate>7/1/2008 1:21:00 PM</pubDate><spcred:price xmlns:spcred="http://www.alacra.com/spcred">400</spcred:price><title>Stryker Corp.</title><spcred:type xmlns:spcred="http://www.alacra.com/spcred">Full Report</spcred:type><spcred:docid xmlns:spcred="http://www.alacra.com/spcred">657331</spcred:docid><spcred:index_entry_dispcountry xmlns:spcred="http://www.alacra.com/spcred">United States</spcred:index_entry_dispcountry><spcred:index_entry_dispgics xmlns:spcred="http://www.alacra.com/spcred">Health Care Equipment</spcred:index_entry_dispgics><spcred:index_entry_dispregion xmlns:spcred="http://www.alacra.com/spcred">United States</spcred:index_entry_dispregion><spcred:index_entry_dispsector xmlns:spcred="http://www.alacra.com/spcred">Global Issuers</spcred:index_entry_dispsector><spcred:index_entry_dispsector xmlns:spcred="http://www.alacra.com/spcred">Corporations</spcred:index_entry_dispsector><spcred:index_entry_dispsector xmlns:spcred="http://www.alacra.com/spcred">Health Care</spcred:index_entry_dispsector><spcred:index_entry_disptype xmlns:spcred="http://www.alacra.com/spcred">Full Report</spcred:index_entry_disptype><spcred:index_entry_excerpt xmlns:spcred="http://www.alacra.com/spcred">Strong positions in orthopedic implants and medical and surgical equipment; Consistent organic growth; and Sustained financial discipline. Concentration in orthopedic implants and related devices (specifically hips and knees); and Distraction of potential recalls. The rating on Kalamazoo, Mich.-based Stryker Corp. reflects the company's strong positions in orthopedic implants and medical and surgical equipment. The company has benefited from consistent organic growth in the orthopedic markets. The rating also reflects Stryker's sustained financial discipline, as well as increasing volumes and stable market shares of the orthopedic products industry. These strengths are offset partially by the company's concentration in orthopedic implants and related devices (specifically hips and knees), which exposes it to potential changes in pricing or medical treatment protocols. Stryker offers</spcred:index_entry_excerpt><spcred:index_entry_primcountry xmlns:spcred="http://www.alacra.com/spcred">USA</spcred:index_entry_primcountry><spcred:index_entry_primcusip xmlns:spcred="http://www.alacra.com/spcred">863667</spcred:index_entry_primcusip><spcred:index_entry_primgics xmlns:spcred="http://www.alacra.com/spcred">35101010 351010 3510 35</spcred:index_entry_primgics><spcred:index_entry_primissuer xmlns:spcred="http://www.alacra.com/spcred">Stryker Corp.</spcred:index_entry_primissuer><spcred:index_entry_primissuerid xmlns:spcred="http://www.alacra.com/spcred">326864</spcred:index_entry_primissuerid><spcred:index_entry_primreg xmlns:spcred="http://www.alacra.com/spcred">USA</spcred:index_entry_primreg><spcred:index_entry_primticker xmlns:spcred="http://www.alacra.com/spcred">SYK</spcred:index_entry_primticker><spcred:index_entry_reporttype xmlns:spcred="http://www.alacra.com/spcred">FULL</spcred:index_entry_reporttype><spcred:index_entry_sector xmlns:spcred="http://www.alacra.com/spcred">GLOBISS</spcred:index_entry_sector><spcred:index_entry_sector xmlns:spcred="http://www.alacra.com/spcred">CORP</spcred:index_entry_sector><spcred:index_entry_sector xmlns:spcred="http://www.alacra.com/spcred">Health</spcred:index_entry_sector><category>Credit &amp; Investment Research</category><alacra:ip>S&amp;P Credit Research</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/spcred/657334</link><guid isPermaLink="false">spcred/657334</guid><spcred:index_mode xmlns:spcred="http://www.alacra.com/spcred">norm</spcred:index_mode><description>The latest Summary from S&amp;P</description><spcred:dataset xmlns:spcred="http://www.alacra.com/spcred">global</spcred:dataset><pubDate>7/1/2008 1:21:00 PM</pubDate><spcred:price xmlns:spcred="http://www.alacra.com/spcred">175</spcred:price><title>Summary: Stryker Corp.</title><spcred:type xmlns:spcred="http://www.alacra.com/spcred">Summary</spcred:type><spcred:docid xmlns:spcred="http://www.alacra.com/spcred">657334</spcred:docid><spcred:index_entry_dispcountry xmlns:spcred="http://www.alacra.com/spcred">United States</spcred:index_entry_dispcountry><spcred:index_entry_dispgics xmlns:spcred="http://www.alacra.com/spcred">Health Care Equipment</spcred:index_entry_dispgics><spcred:index_entry_dispregion xmlns:spcred="http://www.alacra.com/spcred">United States</spcred:index_entry_dispregion><spcred:index_entry_dispsector xmlns:spcred="http://www.alacra.com/spcred">Global Issuers</spcred:index_entry_dispsector><spcred:index_entry_dispsector xmlns:spcred="http://www.alacra.com/spcred">Corporations</spcred:index_entry_dispsector><spcred:index_entry_dispsector xmlns:spcred="http://www.alacra.com/spcred">Health Care</spcred:index_entry_dispsector><spcred:index_entry_disptype xmlns:spcred="http://www.alacra.com/spcred">Summary</spcred:index_entry_disptype><spcred:index_entry_excerpt xmlns:spcred="http://www.alacra.com/spcred">The rating on Kalamazoo, Mich.-based Stryker Corp. reflects the company's strong positions in orthopedic implants and medical and surgical equipment. The company has benefited from consistent organic growth in the orthopedic markets. The rating also reflects Stryker's sustained financial discipline, as well as increasing volumes and stable market shares of the orthopedic products industry. These strengths are offset partially by the company's concentration in orthopedic implants and related devices (specifically hips and knees), which exposes it to potential changes in pricing or medical treatment protocols. Stryker offers a variety of products, including hip and knee replacement systems; screws, plates, and other implants for use in the spine and for trauma; shoulder and elbow implants; bone cement; surgical instrumentation; endoscopy equipment;</spcred:index_entry_excerpt><spcred:index_entry_primcountry xmlns:spcred="http://www.alacra.com/spcred">USA</spcred:index_entry_primcountry><spcred:index_entry_primcusip xmlns:spcred="http://www.alacra.com/spcred">863667</spcred:index_entry_primcusip><spcred:index_entry_primgics xmlns:spcred="http://www.alacra.com/spcred">35101010 351010 3510 35</spcred:index_entry_primgics><spcred:index_entry_primissuer xmlns:spcred="http://www.alacra.com/spcred">Stryker Corp.</spcred:index_entry_primissuer><spcred:index_entry_primissuerid xmlns:spcred="http://www.alacra.com/spcred">326864</spcred:index_entry_primissuerid><spcred:index_entry_primreg xmlns:spcred="http://www.alacra.com/spcred">USA</spcred:index_entry_primreg><spcred:index_entry_primticker xmlns:spcred="http://www.alacra.com/spcred">SYK</spcred:index_entry_primticker><spcred:index_entry_reporttype xmlns:spcred="http://www.alacra.com/spcred">SUMMARY</spcred:index_entry_reporttype><spcred:index_entry_sector xmlns:spcred="http://www.alacra.com/spcred">GLOBISS</spcred:index_entry_sector><spcred:index_entry_sector xmlns:spcred="http://www.alacra.com/spcred">CORP</spcred:index_entry_sector><spcred:index_entry_sector xmlns:spcred="http://www.alacra.com/spcred">Health</spcred:index_entry_sector><category>Credit &amp; Investment Research</category><alacra:ip>S&amp;P Credit Research</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/T1864494</link><guid isPermaLink="false">ccbn/T1864494</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><description>... - Stryker Corporation -  CFO-- and again that business has thrived under orthopedic's leadership. We also, in the same vein, established a dedicated U.S.  trauma business. Again the thought here was we were reasonably penetrated outside the U.S., actually have some markets where they're the number one trauma player, but needed to get the business really going in the U.S. Establishing additional focus and dedication there is something that truly we believe has paid off if you look at the growth rates for our U.S. trauma business I think everyone would agree that that certainly has been the case since we made that move. Similarly, we took a look at our endoscopy and instruments businesses and determined they were not growing as fast overseas and certainly we had much higher penetration rates in the U.S. Again we have had a focus on expanding them outside the U.S. We have divested our physical therapy business last year in the second quarter. We have also boosted our R&amp;D spending. So that...

</description><pubDate>6/12/2008 4:05:00 PM</pubDate><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">Stryker</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">54.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Final</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">Stryker at Goldman Sachs Healthcare Conference Transcript</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">SYK</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">8:00am PT</ccbn:time><title>Stryker at Goldman Sachs Healthcare Conference Transcript</title><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Transcript</ccbn:type><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">T1864494</ccbn:docid><category>Credit &amp; Investment Research</category><alacra:ip>Thomson Street Events</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/T1864491</link><guid isPermaLink="false">ccbn/T1864491</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><description>... - Needham &amp; Company -  AnalystGood morning. I'm Ed Schenk and I cover medical devices and diagnostics at Needham. It's our pleasure to have you listen to  Stryker Corporation. We have with us the CFO today, Dean Bergy. Dean? ...

</description><pubDate>6/11/2008 12:07:00 PM</pubDate><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">Stryker</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">54.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Final</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">Stryker at Needham &amp; Company Biotechnology and Medical Technology Conference Transcript</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">SYK</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">9:00am ET</ccbn:time><title>Stryker at Needham &amp; Company Biotechnology and Medical Technology Conference Transcript</title><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Transcript</ccbn:type><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">T1864491</ccbn:docid><category>Credit &amp; Investment Research</category><alacra:ip>Thomson Street Events</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/T1837450</link><guid isPermaLink="false">ccbn/T1837450</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><description>... - Robert W. Baird -  AnalystGood morning. Why don't we get started? My name is Jeff Johnson. I am the senior medical technology analyst at Baird. Our  next presentation this morning is from Stryker. As you know, Stryker is one of the leading orthopaedic and medical surgical product manufacturers in the world. The last few months have been an interesting time, to say the least, for orthopaedics. And with us today to provide an update on a number of the topics we have all written or read about involving Stryker over the recent months is Vice President, Chief Financial Officer, Dean Bergy. Dean, I will turn it over to you for prepared remarks, then we will open with Q&amp;A. ...

</description><pubDate>5/15/2008 3:04:00 PM</pubDate><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">Stryker</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">54.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Final</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">Stryker at Robert W. Baird &amp; Co., Inc. Growth Stock Conference Transcript</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">SYK</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">10:05am CT</ccbn:time><title>Stryker at Robert W. Baird &amp; Co., Inc. Growth Stock Conference Transcript</title><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Transcript</ccbn:type><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">T1837450</ccbn:docid><category>Credit &amp; Investment Research</category><alacra:ip>Thomson Street Events</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/T1837448</link><guid isPermaLink="false">ccbn/T1837448</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><description>...Let's get started. I'm just going to go through the quick disclosure here. As you are aware, we are required to make a number of conflict of interest and related disclosures in connection with our participation in the conference and the companies we may discuss. If you'd like to review these important disclosures, please pick up the packets containing the public appearance disclosure at the back of the room. PDF copies can be accessed by those of you viewing any of these presentations via webcast. With that, very happy to have with us this morning Stryker Corporation, with me up on the stage Steve MacMillan, President and CEO and Dean Bergy, Chief Operating Officer. Steve will go through the presentation and then we'll do the Q&amp;A from up here.I'll turn it over to Steve. Thanks. ...

</description><pubDate>5/14/2008 6:06:00 PM</pubDate><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">Stryker</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">54.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Final</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">Stryker at Bank of America Securities Health Care Conference Transcript</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">SYK</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">9:20am PT</ccbn:time><title>Stryker at Bank of America Securities Health Care Conference Transcript</title><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Transcript</ccbn:type><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">T1837448</ccbn:docid><category>Credit &amp; Investment Research</category><alacra:ip>Thomson Street Events</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/T1735546</link><guid isPermaLink="false">ccbn/T1735546</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><description>...Good day, ladies and gentlemen and welcome to the Stryker's #### annual meeting -- analyst meeting. Before we begin, the Company has asked me to read the following statement. Certain statements made during this meeting and contained in the presentation may constitute forward-looking statements. They will be based upon management's current expectations and will be subject to various risks and uncertainties that could cause the Company's actual results to differ materially from those exposed or implied in such statements. Such factors include but are not limited to pricing pressure generally including cost-containment measurements that could adversely affect the price of or demands for the Company's products; regulatory actions; unanticipated issues arising in connection with clinical studies and otherwise that affect the United State Food and Drug Administration approval of new products; change in reimbursement levels from third-party payers; a significant increase in product liability claims;...

</description><pubDate>5/12/2008 12:06:00 AM</pubDate><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">Stryker</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">54.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Final</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">Stryker Analyst Meeting Transcript</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">SYK</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">8:00am ET</ccbn:time><title>Stryker Analyst Meeting Transcript</title><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Transcript</ccbn:type><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">T1735546</ccbn:docid><category>Credit &amp; Investment Research</category><alacra:ip>Thomson Street Events</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/T1816733</link><guid isPermaLink="false">ccbn/T1816733</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><description>... - Morgan Stanley -  Analyst, Moderator I think we're going to go ahead and get started here. Good morning, everybody. My name is David Roman. Joining me today  from Stryker is Steve MacMillan, President and Chief Executive Officer, and Katherine Owen, Director of Investor Relations. I hope I didn't botch the titles too much. Why don't we jump right into the reconstructive markets? We now have the benefit of every company having reported earnings, including Smith &amp; Nephew, this morning. Maybe you can just give us some reflections on the overall health of the market, both hips and knees, and where you think we're going for the second quarter and then maybe your broader outlook on the market. ...

</description><pubDate>5/2/2008 6:05:00 PM</pubDate><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">Stryker</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">54.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Final</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">Stryker at Morgan Stanley 2008 Global Healthcare Unplugged Conference Transcript</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">SYK</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">8:00am ET</ccbn:time><title>Stryker at Morgan Stanley 2008 Global Healthcare Unplugged Conference Transcript</title><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Transcript</ccbn:type><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">T1816733</ccbn:docid><category>Credit &amp; Investment Research</category><alacra:ip>Thomson Street Events</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/T1788085</link><guid isPermaLink="false">ccbn/T1788085</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><description>... - Stryker Corporation -  ChairmanGood afternoon, and welcome to the #### Annual Meeting of Shareholders of Stryker Corporation. It's my pleasure to serve as  Chairman of the meeting. And if you've not turned in your proxy and wish to do so, please raise your hand and the Inspector of Election will collect it. I don't see any hands. Okay. Before starting the formal business of this meeting I'd like to introduce the directors of the corporation, all of whom are in attendance today. Howard E. Cox, Junior Partner of Greylock and its affiliated venture capital partnerships. Donald M. Engelman, Ph.D., Eugene Higgins Professor of Molecular Biophysics and Biochemistry, Yale University. Louise L. Francesconi, President of Raytheon Missile Systems. Stephen P. MacMillan, President and Chief Executive Officer of Stryker Corporation. William U. Parfet, Chairman, Chief Executive Officer of MPI Research. Rhonda E. Stryker, granddaughter of Dr. Homer Stryker, the Founder of the Company, and daughter of...

</description><pubDate>4/24/2008 2:07:00 PM</pubDate><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">Stryker</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">54.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Final</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">Annual Shareholder Meeting Transcript</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">SYK</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">2:00pm ET</ccbn:time><title>Annual Shareholder Meeting Transcript</title><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Transcript</ccbn:type><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">T1788085</ccbn:docid><category>Credit &amp; Investment Research</category><alacra:ip>Thomson Street Events</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/newstex/PRN-0005-24585943</link><guid isPermaLink="false">newstex/PRN-0005-24585943</guid><newstex:index_mode xmlns:newstex="http://www.alacra.com/newstex">xml</newstex:index_mode><description> KALAMAZOO, Mich., April ##, Apr. ##, #### (PR Newswire delivered by Newstex) --  KALAMAZOO, Mich., April ## /PRNewswire-FirstCall/ -- Stryker Corporation (NYSE: SYK) reported operating results for the quarter ended March ##, #### as...</description><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016048</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016018</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016047</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016001</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04009000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04009002</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04006000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04006002</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07014000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07014018</newstex:cat><pubDate>4/17/2008 5:14:39 PM</pubDate><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18000000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18008000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18004000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18012000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18010000</newstex:event><newstex:Publication xmlns:newstex="http://www.alacra.com/newstex">PR Newswire US</newstex:Publication><title>Stryker Operating Results for Quarter Ended March 31, 2008</title><newstex:docid xmlns:newstex="http://www.alacra.com/newstex">PRN-0005-24585943</newstex:docid><newstex:index_entry_company xmlns:newstex="http://www.alacra.com/newstex">STRYKER CORP</newstex:index_entry_company><newstex:index_entry_person xmlns:newstex="http://www.alacra.com/newstex">STEPHEN P MACMILLAN</newstex:index_entry_person><newstex:index_entry_ticker xmlns:newstex="http://www.alacra.com/newstex">SYK</newstex:index_entry_ticker><category>News</category><alacra:ip>Newstex</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/T1794777</link><guid isPermaLink="false">ccbn/T1794777</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><description>... - Stryker Corporation -  VP &amp; CFO Okay, I guess we'll get ready to get going here. I'm Dean Bergy, the Vice President and Chief Financial Officer of Stryker Corporation.  And I'd like to welcome you here this morning. I'm going to show you this title for our presentation. It was chosen a while ago although I think it's probably apropos for today's times, particularly the last several days. But certainly Stryker's had a good track record of delivering during uncertain times. And we certainly anticipate that we will be able to continue that track record as we go forward here. So let me recap some of the goals that the company had in ####. As we began ####, it was our intention to deliver a seventh straight year of double digit sales growth. Certainly that would put us in [argots] company one of less than ## companies in the Fortune ### and in the S&amp;P ### that has been able to do that. Earnings goal of-- growing earnings EPS up ##% and strong execution while looking for new opportunities....

</description><pubDate>3/18/2008 3:05:00 PM</pubDate><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">Stryker</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">54.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Final</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">Stryker at Lehman Brothers Healthcare Conference Transcript</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">SYK</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">10:15am ET</ccbn:time><title>Stryker at Lehman Brothers Healthcare Conference Transcript</title><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Transcript</ccbn:type><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">T1794777</ccbn:docid><category>Credit &amp; Investment Research</category><alacra:ip>Thomson Street Events</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/T1779808</link><guid isPermaLink="false">ccbn/T1779808</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><description>... - Cowen and Company -  Medical Advice Equity Research Team Good morning, we're going to go ahead and get started. My name is Doug Shenkel. I'm one of the senior analysts with Cowen's  Medical Advice Equity Research Team. It's my pleasure to introduce Katherine Owen, Stryker's Vice President of Strategy and Investor Relations. Before I turn it over to Katherine, I do want to note that a question-and-answer breakout session will be held subsequent to this presentation here on the third floor in the [Tough] Suite. That begins at ##:##. We probably will have some time for Q-and-A here in advance of that. So with that, it's my pleasure to turn the mic over to Katherine. ...

</description><pubDate>3/17/2008 8:05:00 PM</pubDate><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">Stryker</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">54.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Final</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">Stryker at Cowen and Company Health Care Conference Transcript</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">SYK</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">11:30am ET</ccbn:time><title>Stryker at Cowen and Company Health Care Conference Transcript</title><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Transcript</ccbn:type><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">T1779808</ccbn:docid><category>Credit &amp; Investment Research</category><alacra:ip>Thomson Street Events</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/bir/308284</link><guid isPermaLink="false">bir/308284</guid><bir:index_mode xmlns:bir="http://www.alacra.com/bir">norm</bir:index_mode><title>Stryker Corp.</title><bir:company xmlns:bir="http://www.alacra.com/bir">Stryker Corp.</bir:company><bir:company xmlns:bir="http://www.alacra.com/bir">Image Guided Technologies Inc.</bir:company><bir:company xmlns:bir="http://www.alacra.com/bir">Surgical Dynamics Inc</bir:company><bir:cou xmlns:bir="http://www.alacra.com/bir">United States</bir:cou><bir:descr xmlns:bir="http://www.alacra.com/bir">Manufacturing: Orthopedic, surgical, medical and exercise equipment, operating room machinery and patient beds.</bir:descr><bir:sic xmlns:bir="http://www.alacra.com/bir">3841</bir:sic><bir:ssic xmlns:bir="http://www.alacra.com/bir">3842</bir:ssic><bir:ssic xmlns:bir="http://www.alacra.com/bir">3844</bir:ssic><bir:naics xmlns:bir="http://www.alacra.com/bir">339112</bir:naics><bir:snaics xmlns:bir="http://www.alacra.com/bir">334517</bir:snaics><bir:snaics xmlns:bir="http://www.alacra.com/bir">339113</bir:snaics><bir:class xmlns:bir="http://www.alacra.com/bir">2</bir:class><bir:class xmlns:bir="http://www.alacra.com/bir">17</bir:class><bir:size xmlns:bir="http://www.alacra.com/bir">I</bir:size><bir:revenue xmlns:bir="http://www.alacra.com/bir">L</bir:revenue><bir:ticker xmlns:bir="http://www.alacra.com/bir">SYK</bir:ticker><pubDate>3/8/2008 6:21:00 AM</pubDate><bir:docid xmlns:bir="http://www.alacra.com/bir">308284</bir:docid><category>Company Profiles &amp; Financials</category><alacra:ip>Gale Company Profiles</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/T1754504</link><guid isPermaLink="false">ccbn/T1754504</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><description>Stryker at Merrill Lynch ##th Global Pharmaceutical, Biotechnology &amp; Medical Device Conference</description><pubDate>2/6/2008 10:06:00 PM</pubDate><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">Stryker</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">54.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Final</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">Stryker at Merrill Lynch 19th Global Pharmaceutical, Biotechnology &amp; Medical Device Conference Transcript</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">SYK</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">2:20pm ET</ccbn:time><title>Stryker at Merrill Lynch 19th Global Pharmaceutical, Biotechnology &amp; Medical Device Conference Transcript</title><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Transcript</ccbn:type><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">T1754504</ccbn:docid><category>Credit &amp; Investment Research</category><alacra:ip>Thomson Street Events</alacra:ip></item></channel></rss>